The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
600 - 1,000 jobs Number of planned job losses
Announcement Date
16 September 2014
Employment effect (start)
1 January 2015
Foreseen end date
31 December 2018
Description
Pharmaceutical company Boehringer Ingelheim announced plans to cut up to 600 jobs in Germany by 2016. As reported, in the framework of a cost saving restructuring plan due to weak success of certain products and a decreasing turnover, the group announced its intention to cut approximately 1,000 jobs in Germany by the end of 2018 aiming at 15pc or € 450 million cost reduction. According to the sources, the company has started negotiations with the employee representatives and the final decision will be made by the end of 2014.
As mentioned by the company, most possibly there will be no forced redundancies and the measure will be based in hiring freeze and non-replacement of jobs lost through natural attrition. The sites in Dortmund and Hannover, as well as the biopharmaceutical production in Biberach and the production in Ingelheim will not be affected.
Boehringer Ingelheim has approximately 14,000 staff in Germany and 46,000 worldwide.
Sources
17 September 2014: FAZ
23 September 2014: FAZ
16 September 2014: Handelsblatt
17 September 2014: Handelsblatt
Citation
Eurofound (2014), Boehringer Ingelheim, Internal restructuring in Germany, factsheet number 77570, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/77570.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...